Evidence map›Paper›PMID 20656684›Full record

ArticleThe Journal of biological chemistry2010

Formation of a ternary complex among NHERF1, beta-arrestin, and parathyroid hormone receptor.

Christoph Klenk, Thorsten Vetter, Alexander Zürn, Jean-Pierre Vilardaga, Peter A Friedman, Bin Wang, Martin J Lohse

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Christoph KlenkInstitute of Pharmacology and Toxicology, University of Würzburg, 97078 Würzburg, Germany.
Thorsten Vetter
Alexander Zürn
Jean-Pierre Vilardaga
Peter A Friedman
Bin Wang
Martin J Lohse
University of Würzburg · DEUniversity of Pittsburgh · USHarvard University · US

Funding

PTH Receptor: Posttranslational Modification and Recycling in BoneR01DK054171 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FRIEDMAN, PETER A · 1998 to 2015
$6.0M
EBP50 REGULATION OF PTH RECEPTOR IN BONE AND KIDNEYR01DK069998 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FRIEDMAN, PETER A · 2006 to 2014
$2.9M
Sustained cAMP Signals Triggered by Internalized PTH Receptor: New Consequences fR01DK087688 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VILARDAGA, JEAN-PIERRE · 2010 to 2014
$1.6M
NIDDK NIH HHS DK069998NIDDK NIH HHS DK087688NIDDK NIH HHS DK54171NIDDK NIH HHS R01 DK054171NIDDK NIH HHS R01 DK069998NIDDK NIH HHS R01 DK087688
6 · The paper itself

Abstract

β-Arrestins are crucial regulators of G-protein coupled receptor (GPCR) signaling, desensitization, and internalization. Despite the long-standing paradigm that agonist-promoted receptor phosphorylation is required for β-arrestin2 recruitment, emerging evidence suggests that phosphorylation-independent mechanisms play a role in β-arrestin2 recruitment by GPCRs. Several PDZ proteins are known to interact with GPCRs and serve as cytosolic adaptors to modulate receptor signaling and trafficking. Na(+)/H(+) exchange regulatory factors (NHERFs) exert a major role in GPCR signaling. By combining imaging and biochemical and biophysical methods we investigated the interplay among NHERF1, β-arrestin2, and the parathyroid hormone receptor type 1 (PTHR). We show that NHERF1 and β-arrestin2 can independently bind to the PTHR and form a ternary complex in cultured human embryonic kidney cells and Chinese hamster ovary cells. Although NHERF1 interacts constitutively with the PTHR, β-arrestin2 binding is promoted by receptor activation. NHERF1 interacts directly with β-arrestin2 without using the PTHR as an interface. Fluorescence resonance energy transfer studies revealed that the kinetics of PTHR and β-arrestin2 interactions were modulated by NHERF1. These findings suggest a model in which NHERF1 may serve as an adaptor, bringing β-arrestin2 into close proximity to the PTHR, thereby facilitating β-arrestin2 recruitment after receptor activation.

Indexed as

AnimalsArrestinsbeta-ArrestinsCHO CellsCricetinaeCricetulusHumansMultiprotein ComplexesPhosphoproteinsProtein Structure, QuaternaryReceptor, Parathyroid Hormone, Type 1Signal TransductionSodium-Hydrogen ExchangersArrestinsbeta-ArrestinsMultiprotein ComplexesPhosphoproteinsPTH1R protein, humanReceptor, Parathyroid Hormone, Type 1sodium-hydrogen exchanger regulatory factorSodium-Hydrogen Exchangers

Identifiers

PMID20656684
PMCPMC2943313
OpenAlexW2090071443

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.